FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/074912 [Registered on: 08/10/2024] Trial Registered Prospectively
Last Modified On: 04/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   The study examines the effect of two doses of intravenous dexmedetomidine on emergence agitation in pediatric patients undergoing inguinal hernia surgeries with general anesthesia using sevoflurane. It aims to determine whether dexmedetomidine can reduce agitation during recovery.  
Scientific Title of Study   Comparison of two doses of intravenous Dexmedetomidine on emergence agitation in paediatric patients undergoing inguinal hernia surgeries under general anaesthesia with sevoflurane  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ankit 
Designation  PG resident 
Affiliation  VMMC and SJH 
Address  Department of Anaesthesia and Intensive Care, Ground floor, Main OT building, Vardhman Mahavir Medical College and Safdarjung Hospital, Ansari Nagar, New Delhi - 110029 South DELHI 110029

South
DELHI
110029
India 
Phone  9582524264  
Fax    
Email  ankitvermaatvmmc@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR MEENAKSHI KUMAR 
Designation  Consultant and Professor 
Affiliation  VMMC and SJH 
Address  Department of Anaesthesia and Intensive Care, Ground floor, Main OT building, Vardhman Mahavir Medical College and Safdarjung Hospital, Ansari Nagar, New Delhi - 110029 South DELHI 110029

South
DELHI
110029
India 
Phone  9899689829  
Fax    
Email  drmeenakshi86@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  DR MEENAKSHI KUMAR 
Designation  Consultant and Professor 
Affiliation  VMMC and SJH 
Address  Department of Anaesthesia and Intensive Care, Ground floor, Main OT building, Vardhman Mahavir Medical College and Safdarjung Hospital, Ansari Nagar, New Delhi - 110029 South DELHI 110029


DELHI
110029
India 
Phone  9899689829  
Fax    
Email  drmeenakshi86@yahoo.com  
 
Source of Monetary or Material Support  
Department of Anaesthesia and Intensive Care, Ground Floor, Main OT Complex, VMMC & Safdarjung Hospital, Ansari Nagar(in front of AIIMS), New Delhi - 110029 
 
Primary Sponsor  
Name  Vmmc and SJH 
Address  Department of Anaesthesia and Intensive Care, Ground floor, Main OT building, Vardhman Mahavir Medical College and Safdarjung Hospital, Ansari Nagar, New Delhi - 110029 South DELHI 110029 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ankit  Vardhman Mahavir Medical College and Safdarjung Hospital  Department of Anaesthesia and Intensive Care, Vardhman Mahavir Medical College and Safdarjung Hospital, Ansari Nagar, New Delhi - 110029 South DELHI
South
DELHI 
9582524264

ankitvermaatvmmc@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Vardhman Mahavir Medical College and Safdarjung Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dexmedetomidine   0.25µg/kg of Dexmedetomidine diluted in 5ml NaCl 0.9% over a period of 5 min 
Comparator Agent  Dexmedetomidine  0.5µg/kg of Dexmedetomidine diluted in 5ml NaCl 0.9% over a period of 5 min 
 
Inclusion Criteria  
Age From  1.00 Year(s)
Age To  6.00 Year(s)
Gender  Both 
Details  Patients aged 1-6 years fulfilling the criteria of American Society of Anesthesiologists physical
status I and II undergoing inguinal hernia surgeries under general
anaesthesia with sevoflurane will be included in the study. 
 
ExclusionCriteria 
Details  The patients with following history will be excluded from the study:
1. Allergy to any of the drugs use
2. Known Congenital heart disease 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To compare the effect of two doses of Dexmedetomidine on the incidence of emergence
agitation in pediatric patients undergoing inguinal hernia surgeries under general anaesthesia
with sevoflurane by using the PAED scale. 
0min ,10min ,20min ,30min ,40min after extubation 
 
Secondary Outcome  
Outcome  TimePoints 
1. To study the recovery profile in terms of emergence time, extubation time, and
discharge time from the recovery room using the Steward recovery score.
2. FLACC Score – To assess postoperative analgesia.
3. To study Intraop and Postop hemodynamic parameters
4. Postop Fentanyl requirement. 
40 minutes after extubation  
 
Target Sample Size   Total Sample Size="62"
Sample Size from India="62" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   15/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="5"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Emergence agitation is commonly seen in children during recovery from general anaesthesia.1
It is associated with symptoms such as combative movements, excitability, thrashing,
disorientation, inconsolable crying, and restlessness.
2 This behaviour results in anxiety, delayed
discharge from the post anesthestic care unit, and creates problems for parents as well as
caregivers.
3 It occurs for a short duration, but it may require pharmacological intervention,
resulting in a prolonged post-anesthesia care unit stay. As, the pathophysiology is unknown but
risk factors include preschool age, preoperative anxiety, postoperative pain, nausea, vomiting,
and inhalational anaesthetics specially sevoflurane.4
Dexmedetomidine is a highly potent and selective alpha-2 adrenoreceptor which has sedative,
anxiolytic, and analgesic properties without significant respiratory depression.
9 It has been used
effectively in intensive care to aid weaning from mechanical ventilation and now is being
utilized increasingly in paediatric anaesthesia.5 It has been used by various authors intranasally
and intravenously as a bolus and continuous intravenous (IV) infusion to suppress the incidence
of EA in various surgeries such as adenotonsillectomy, cleft lip & palate repair, and strabismus
correction.3,5,10 Limited literature is available regarding the lowest dose of Dexmedetomidine
for the prevention of emergency agitation in paediatric patients. Therefore, in this study, we are
planning to evaluate the effect of low dose of intravenous Dexmedetomidine on emergence
agitation in paediatric patients undergoing inguinal hernia surgeries under general anesthesia with sevoflurane
 
Close